| Dr Pradip Bhattacharjee, MD | |
|
65 Rancho Mirage Ct, Holmdel, NJ 07733-2555 | |
| (330) 219-4361 | |
| Not Available |
| Full Name | Dr Pradip Bhattacharjee |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 26 Years |
| Location | 65 Rancho Mirage Ct, Holmdel, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124351747 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Dermatology Clinic Llc | 8426463738 | 3 |
| Morgan Dermatology | 9537319868 | 7 |
| Atlantic Dermatologic Associates, Llp | 8022900869 | 10 |
| Clearsolutions Dermatology Group | 4981078953 | 2 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.
The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities - an achievement that could lead to advances in studying and treating neurological disease.
› Verified 7 days ago
| Entity Name | Dermatology And Skin Surgery Center, Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811129141 PECOS PAC ID: 8426194036 Enrollment ID: O20091013000525 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.
The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities - an achievement that could lead to advances in studying and treating neurological disease.
› Verified 7 days ago
| Entity Name | Patricia C Mccormack Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700184884 PECOS PAC ID: 7810150109 Enrollment ID: O20120524000225 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.
The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities - an achievement that could lead to advances in studying and treating neurological disease.
› Verified 7 days ago
| Entity Name | Morgan Dermatology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457613309 PECOS PAC ID: 9537319868 Enrollment ID: O20121023000624 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.
The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities - an achievement that could lead to advances in studying and treating neurological disease.
› Verified 7 days ago
| Entity Name | Premier Dermatology Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598354995 PECOS PAC ID: 8426463738 Enrollment ID: O20210219000245 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.
The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities - an achievement that could lead to advances in studying and treating neurological disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pradip Bhattacharjee, MD 7 Jewel Ct, Marlboro, NJ 07746-2059 Ph: (732) 856-4022 | Dr Pradip Bhattacharjee, MD 65 Rancho Mirage Ct, Holmdel, NJ 07733-2555 Ph: (330) 219-4361 |
News Archive
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has treated the first patient in a pilot clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.
The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities - an achievement that could lead to advances in studying and treating neurological disease.
› Verified 7 days ago
Hongling Wang, MD Pathology Medicare: Medicare Enrolled Practice Location: 727 N Beers St, Holmdel, NJ 07733 Phone: 732-739-5847 | |
Wei Hong, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 727 N Beers St, Meridian Bayshore Community Hospital, Dept Of Pathlogy, Holmdel, NJ 07733 Phone: 732-739-5847 Fax: 732-888-5243 | |
Dharmishtha Jayesh Kanuga, Pathology Medicare: Not Enrolled in Medicare Practice Location: 6 Thistle Ln, Holmdel, NJ 07733 Phone: 732-275-9001 |